NFKB1 and oral cavity squamous cell carcinoma: For example, Huang Z et al. showed that vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3 [52].